Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 212

1.

Health risk associated with the oral consumption of "Chiniy-tref", a traditional medicinal preparation used in Martinique (French West Indies): Qualitative and quantitative analyses of aristolochic acids contained therein.

Riffault-Valois L, Wattez C, Langrand J, Boucaud-Maitre D, Gaslonde T, Colas C, Nossin E, Blateau A, Michel S, Cachet X.

Toxicon. 2019 Nov 5. pii: S0041-0101(19)30724-X. doi: 10.1016/j.toxicon.2019.10.241. [Epub ahead of print]

PMID:
31704310
2.

Characterization of liquid-liquid extraction fractions from lignocellulosic biomass by high performance liquid chromatography hyphenated to tandem high-resolution mass spectrometry.

Reymond C, Dubuis A, Le Masle A, Colas C, Chahen L, Destandau E, Charon N.

J Chromatogr A. 2019 Sep 25:460569. doi: 10.1016/j.chroma.2019.460569. [Epub ahead of print]

PMID:
31585675
3.

The Tumor-Immune Response Is Not Compromised by Mesenchymal Stromal Cells in Humanized Mice.

Moquin-Beaudry G, Colas C, Li Y, Bazin R, Guimond JV, Haddad E, Beauséjour C.

J Immunol. 2019 Nov 15;203(10):2735-2745. doi: 10.4049/jimmunol.1900807. Epub 2019 Oct 2.

PMID:
31578272
4.

[Familial disclosure by healthcare professionals in absence of genetic mutation].

de Pauw A, Derbez B, Colas C, de Montgolfier S, Stoppa-Lyonnet D.

Presse Med. 2019 Sep;48(9):886-891. doi: 10.1016/j.lpm.2019.08.015. Epub 2019 Sep 20. French. No abstract available.

PMID:
31548116
5.

Medulloblastomas associated with APC germline pathogenic variant share the good prognosis of CTNNB1 mutated medulloblastomas.

Surun A, Varlet P, Brugières L, Lacour B, Faure-Conter C, Leblond P, Bertozzi-Salomon AI, Berger C, André N, Sariban E, Raimbault S, Prieur F, Desseigne F, Zattara H, Guimbaud R, Polivka M, Delisle MB, Vasiljevic A, Maurage CA, Figarella-Branger D, Coulet F, Guerrini-Rousseau L, Alapetite C, Dufour C, Colas C, Doz F, Bourdeaut F.

Neuro Oncol. 2019 Aug 23. pii: noz154. doi: 10.1093/neuonc/noz154. [Epub ahead of print]

PMID:
31504825
6.

Back-to-Back Comparison of Colonoscopy With Virtual Chromoendoscopy Using a Third-Generation Narrow-Band Imaging System to Chromoendoscopy With Indigo Carmine in Patients With Lynch Syndrome.

Cellier C, Perrod G, Colas C, Dhooge M, Saurin JC, Lecomte T, Coron E, Rahmi G, Savale C, Chaussade S, Bellanger J, Dray X, Benech N, Le Rhun M, Barbieux JP, Pereira H, Chatellier G, Samaha E.

Am J Gastroenterol. 2019 Oct;114(10):1665-1670. doi: 10.14309/ajg.0000000000000386.

PMID:
31498154
7.

A rational strategy based on experimental designs to optimize parameters of a liquid chromatography-mass spectrometry analysis of complex matrices.

Reymond C, Le Masle A, Colas C, Charon N.

Talanta. 2019 Dec 1;205:120063. doi: 10.1016/j.talanta.2019.06.063. Epub 2019 Jun 18.

PMID:
31450446
8.

Monitoring of phosphorylation using immobilized kinases by on-line enzyme bioreactors hyphenated with High-Resolution Mass Spectrometry.

Ferey J, Da Silva D, Colas C, Lafite P, Topalis D, Roy V, Agrofoglio LA, Daniellou R, Maunit B.

Talanta. 2019 Dec 1;205:120120. doi: 10.1016/j.talanta.2019.120120. Epub 2019 Jul 5.

PMID:
31450426
9.

Familial pancreatic adenocarcinoma: A retrospective analysis of germline genetic testing in a French multicentre cohort.

Schwartz M, Korenbaum C, Benfoda M, Mary M, Colas C, Coulet F, Parrin M, Jonveaux P, Ingster O, Granier S, De Mestier L, Cros J, Riffault A, Muller M, Levy P, Rebours V, Greenhalf W, Soufir N, Hammel P.

Clin Genet. 2019 Aug 21. doi: 10.1111/cge.13629. [Epub ahead of print]

PMID:
31432501
10.

Early Colorectal Cancers Provide New Evidence for a Lynch Syndrome-to-CMMRD Phenotypic Continuum.

Fernandez-Rozadilla C, Alvarez-Barona M, Schamschula E, Bodo S, Lopez-Novo A, Dacal A, Calviño-Costas C, Lancho A, Amigo J, Bello X, Cameselle-Teijeiro JM, Carracedo A, Colas C, Muleris M, Wimmer K, Ruiz-Ponte C.

Cancers (Basel). 2019 Jul 30;11(8). pii: E1081. doi: 10.3390/cancers11081081.

11.

A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice.

Roth C, Cantaert T, Colas C, Prot M, Casadémont I, Levillayer L, Thalmensi J, Langlade-Demoyen P, Gerke C, Bahl K, Ciaramella G, Simon-Loriere E, Sakuntabhai A.

Front Immunol. 2019 Jun 21;10:1424. doi: 10.3389/fimmu.2019.01424. eCollection 2019.

12.

l-Type amino acid transporter 1 activity of 1,2,3-triazolyl analogs of l-histidine and l-tryptophan.

Hall C, Wolfe H, Wells A, Chien HC, Colas C, Schlessinger A, Giacomini KM, Thomas AA.

Bioorg Med Chem Lett. 2019 Aug 15;29(16):2254-2258. doi: 10.1016/j.bmcl.2019.06.033. Epub 2019 Jun 20.

PMID:
31248771
13.

An alternative approach to establishing unbiased colorectal cancer risk estimation in Lynch syndrome.

Suerink M, Rodríguez-Girondo M, van der Klift HM, Colas C, Brugieres L, Lavoine N, Jongmans M, Munar GC, Evans DG, Farrell MP, Genuardi M, Goldberg Y, Gomez-Garcia E, Heinimann K, Hoell JI, Aretz S, Jasperson KW, Kedar I, Modi MB, Nikolaev S, van Os TAM, Ripperger T, Rueda D, Senter L, Sjursen W, Sunde L, Therkildsen C, Tibiletti MG, Trainer AH, Vos YJ, Wagner A, Winship I, Wimmer K, Zimmermann SY, Vasen HF, van Asperen CJ, Houwing-Duistermaat JJ, Ten Broeke SW, Nielsen M.

Genet Med. 2019 Jun 17. doi: 10.1038/s41436-019-0577-z. [Epub ahead of print]

PMID:
31204389
14.

Adaptation to Spanish and validation of the Rhinitis Control Assessment Test (RCAT) questionnaire.

Del Cuvillo A, Sastre J, Colás C, Navarro AM, Mullol J, Valero A.

J Investig Allergol Clin Immunol. 2019 May 28:0. doi: 10.18176/jiaci.0420. [Epub ahead of print]

15.

Methylation Tolerance-Based Functional Assay to Assess Variants of Unknown Significance in the MLH1 and MSH2 Genes and Identify Patients With Lynch Syndrome.

Bouvet D, Bodo S, Munier A, Guillerm E, Bertrand R, Colas C, Duval A, Coulet F, Muleris M.

Gastroenterology. 2019 Aug;157(2):421-431. doi: 10.1053/j.gastro.2019.03.071. Epub 2019 Apr 15.

PMID:
30998989
17.

"Decoding hereditary breast cancer" benefits and questions from multigene panel testing.

Colas C, Golmard L, de Pauw A, Caputo SM, Stoppa-Lyonnet D.

Breast. 2019 Jun;45:29-35. doi: 10.1016/j.breast.2019.01.002. Epub 2019 Jan 8.

PMID:
30822622
18.

Endoscopic Phenotype of Monoallelic Carriers of MUTYH Gene Mutations in the Family of Polyposis Patients: A Prospective Study.

El Hachem N, Abadie C, Longy M, Colas C, Fert-Ferrer S, Leroux D, Grandval P, Prieur F, Collonge-Rame M, Faivre L, Fricker JP, Zerbib F, Coupier I, Cauchin E, Pinson S, Saurin JC.

Dis Colon Rectum. 2019 Apr;62(4):470-475. doi: 10.1097/DCR.0000000000001323.

PMID:
30640315
19.

Prevalence of Pathogenic Variants of FAN1 in More Than 5000 Patients Assessed for Genetic Predisposition to Colorectal, Breast, Ovarian, or Other Cancers.

Fievet A, Mouret-Fourme E, Colas C, de Pauw A, Stoppa-Lyonnet D, Buecher B.

Gastroenterology. 2019 May;156(6):1919-1920. doi: 10.1053/j.gastro.2019.01.003. Epub 2019 Jan 9. No abstract available.

PMID:
30639725
20.

Monitoring of successive phosphorylations of thymidine using free and immobilized human nucleoside/nucleotide kinases by Flow Injection Analysis with High-Resolution Mass Spectrometry.

Ferey J, Da Silva D, Colas C, Nehmé R, Lafite P, Roy V, Morin P, Daniellou R, Agrofoglio L, Maunit B.

Anal Chim Acta. 2019 Feb 21;1049:115-122. doi: 10.1016/j.aca.2018.10.032. Epub 2018 Oct 17.

PMID:
30612642
21.

[Constitutional MMR deficiency: Genetic bases and clinical implications].

Buecher B, Le Mentec M, Doz F, Bourdeaut F, Gauthier-Villars M, Stoppa-Lyonnet D, Colas C.

Bull Cancer. 2019 Feb;106(2):162-172. doi: 10.1016/j.bulcan.2018.10.008. Epub 2018 Dec 11. Review. French.

PMID:
30551794
22.

Clinical implications of CTNNA1 germline mutations in asymptomatic carriers.

Benusiglio PR, Colas C, Guillerm E, Canard A, Delhomelle H, Warcoin M, Bellanger J, Eyries M, Zizi M, Netter J, Soubrier F, Parc Y, Mourregot A, Maran Gonzalez A, Cusin V, Denis JA, Coupier I, Svrcek M, Coulet F.

Gastric Cancer. 2019 Jul;22(4):899-903. doi: 10.1007/s10120-018-00907-7. Epub 2018 Dec 4.

PMID:
30515673
23.

The LPG1x family from Leishmania major is constituted of rare eukaryotic galactofuranosyltransferases with unprecedented catalytic properties.

Ati J, Colas C, Lafite P, Sweeney RP, Zheng RB, Lowary TL, Daniellou R.

Sci Rep. 2018 Dec 4;8(1):17566. doi: 10.1038/s41598-018-35847-w.

24.

Constitutional mismatch repair deficiency as a differential diagnosis of neurofibromatosis type 1: consensus guidelines for testing a child without malignancy.

Suerink M, Ripperger T, Messiaen L, Menko FH, Bourdeaut F, Colas C, Jongmans M, Goldberg Y, Nielsen M, Muleris M, van Kouwen M, Slavc I, Kratz C, Vasen HF, Brugiѐres L, Legius E, Wimmer K.

J Med Genet. 2019 Feb;56(2):53-62. doi: 10.1136/jmedgenet-2018-105664. Epub 2018 Nov 10.

PMID:
30415209
25.

Site-Specific Conjugation of Auristatins onto Engineered scFv Using Second Generation Maleimide to Target HER2-positive Breast Cancer in Vitro.

Aubrey N, Allard-Vannier E, Martin C, Bryden F, Letast S, Colas C, Lakhrif Z, Collinet N, Dimier-Poisson I, Chourpa I, Viaud-Massuard MC, Joubert N.

Bioconjug Chem. 2018 Nov 21;29(11):3516-3521. doi: 10.1021/acs.bioconjchem.8b00668. Epub 2018 Oct 25.

PMID:
30352511
26.

Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing.

Girard E, Eon-Marchais S, Olaso R, Renault AL, Damiola F, Dondon MG, Barjhoux L, Goidin D, Meyer V, Le Gal D, Beauvallet J, Mebirouk N, Lonjou C, Coignard J, Marcou M, Cavaciuti E, Baulard C, Bihoreau MT, Cohen-Haguenauer O, Leroux D, Penet C, Fert-Ferrer S, Colas C, Frebourg T, Eisinger F, Adenis C, Fajac A, Gladieff L, Tinat J, Floquet A, Chiesa J, Giraud S, Mortemousque I, Soubrier F, Audebert-Bellanger S, Limacher JM, Lasset C, Lejeune-Dumoulin S, Dreyfus H, Bignon YJ, Longy M, Pujol P, Venat-Bouvet L, Bonadona V, Berthet P, Luporsi E, Maugard CM, Noguès C, Delnatte C, Fricker JP, Gesta P, Faivre L, Lortholary A, Buecher B, Caron O, Gauthier-Villars M, Coupier I, Servant N, Boland A, Mazoyer S, Deleuze JF, Stoppa-Lyonnet D, Andrieu N, Lesueur F.

Int J Cancer. 2019 Apr 15;144(8):1962-1974. doi: 10.1002/ijc.31921. Epub 2018 Nov 13.

27.

[The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition].

Moretta J, Berthet P, Bonadona V, Caron O, Cohen-Haguenauer O, Colas C, Corsini C, Cusin V, De Pauw A, Delnatte C, Dussart S, Jamain C, Longy M, Luporsi E, Maugard C, Nguyen TD, Pujol P, Vaur D, Andrieu N, Lasset C, Noguès C; Groupe Génétique et Cancer d’Unicancer.

Bull Cancer. 2018 Oct;105(10):907-917. doi: 10.1016/j.bulcan.2018.08.003. Epub 2018 Sep 27. French.

PMID:
30268633
28.

Clerodane furanoditerpenoids as the probable cause of toxic hepatitis induced by Tinospora crispa.

Cachet X, Langrand J, Riffault-Valois L, Bouzidi C, Colas C, Dugay A, Michel S, Boucaud-Maitre D.

Sci Rep. 2018 Sep 10;8(1):13520. doi: 10.1038/s41598-018-31815-6.

29.

A Hypoallergenic Polygalacturonase Isoform from Olive Pollen Is Implicated in Pollen-Pollen Cross-Reactivity.

Oeo-Santos C, Mas S, Quiralte J, Colás C, Blanca M, Fernández J, Feo Brito F, Villalba M, Barderas R.

Int Arch Allergy Immunol. 2018;177(4):290-301. doi: 10.1159/000491027. Epub 2018 Aug 31.

PMID:
30173224
30.

Homology Modeling Informs Ligand Discovery for the Glutamine Transporter ASCT2.

Garibsingh RA, Otte NJ, Ndaru E, Colas C, Grewer C, Holst J, Schlessinger A.

Front Chem. 2018 Jul 24;6:279. doi: 10.3389/fchem.2018.00279. eCollection 2018.

31.

Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1).

Chien HC, Colas C, Finke K, Springer S, Stoner L, Zur AA, Venteicher B, Campbell J, Hall C, Flint A, Augustyn E, Hernandez C, Heeren N, Hansen L, Anthony A, Bauer J, Fotiadis D, Schlessinger A, Giacomini KM, Thomas AA.

J Med Chem. 2018 Aug 23;61(16):7358-7373. doi: 10.1021/acs.jmedchem.8b01007. Epub 2018 Aug 10.

32.

No Overt Clinical Immunodeficiency Despite Immune Biological Abnormalities in Patients With Constitutional Mismatch Repair Deficiency.

Tesch VK, IJspeert H, Raicht A, Rueda D, Dominguez-Pinilla N, Allende LM, Colas C, Rosenbaum T, Ilencikova D, Baris HN, Nathrath MHM, Suerink M, Januszkiewicz-Lewandowska D, Ragab I, Azizi AA, Wenzel SS, Zschocke J, Schwinger W, Kloor M, Blattmann C, Brugieres L, van der Burg M, Wimmer K, Seidel MG.

Front Immunol. 2018 Jul 2;9:1506. doi: 10.3389/fimmu.2018.01506. eCollection 2018.

33.

Investigation of Linum flavum (L.) Hairy Root Cultures for the Production of Anticancer Aryltetralin Lignans.

Renouard S, Corbin C, Drouet S, Medvedec B, Doussot J, Colas C, Maunit B, Bhambra AS, Gontier E, Jullian N, Mesnard F, Boitel M, Abbasi BH, Arroo RRJ, Lainé E, Hano C.

Int J Mol Sci. 2018 Mar 26;19(4). pii: E990. doi: 10.3390/ijms19040990.

34.

Effects of Mutations and Ligands on the Thermostability of the l-Arginine/Agmatine Antiporter AdiC and Deduced Insights into Ligand-Binding of Human l-Type Amino Acid Transporters.

Ilgü H, Jeckelmann JM, Colas C, Ucurum Z, Schlessinger A, Fotiadis D.

Int J Mol Sci. 2018 Mar 20;19(3). pii: E918. doi: 10.3390/ijms19030918.

35.

Metachronous colorectal cancer risk in Lynch syndrome patients-should the endoscopic surveillance be more intensive?

Anyla M, Lefevre JH, Creavin B, Colas C, Svrcek M, Lascols O, Debove C, Chafai N, Tiret E, Parc Y.

Int J Colorectal Dis. 2018 Jun;33(6):703-708. doi: 10.1007/s00384-018-3004-z. Epub 2018 Mar 12.

PMID:
29532206
36.

Imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1 decrease the parasite burden in mice with acute toxoplasmosis.

Moine E, Moiré N, Dimier-Poisson I, Brunet K, Couet W, Colas C, Van Langendonck N, Enguehard-Gueiffier C, Gueiffier A, Héraut B, Denevault-Sabourin C, Debierre-Grockiego F.

Int J Parasitol. 2018 Jun;48(7):561-568. doi: 10.1016/j.ijpara.2017.12.006. Epub 2018 Mar 7.

PMID:
29524527
37.

Impact of cathepsin B-sensitive triggers and hydrophilic linkers on in vitro efficacy of novel site-specific antibody-drug conjugates.

Bryden F, Martin C, Letast S, Lles E, Viéitez-Villemin I, Rousseau A, Colas C, Brachet-Botineau M, Allard-Vannier E, Larbouret C, Viaud-Massuard MC, Joubert N.

Org Biomol Chem. 2018 Mar 14;16(11):1882-1889. doi: 10.1039/c7ob02780j.

PMID:
29473076
38.

Position paper on nasal obstruction: evaluation and treatment.

Valero A, Navarro AM, Del Cuvillo A, Alobid I, Benito JR, Colás C, de Los Santos G, Fernández Liesa R, García-Lliberós A, González-Pérez R, Izquierdo-Domínguez A, Jurado-Ramos A, Lluch-Bernal MM, Montserrat Gili JR, Mullol J, Puiggròs Casas A, Sánchez-Hernández MC, Vega F, Villacampa JM, Armengot-Carceller M, Dordal MT; SEAIC Rhinoconjunctivitis Committee & SEORL Rhinology, Allergy, and Skull Base Committee.

J Investig Allergol Clin Immunol. 2018;28(2):67-90. doi: 10.18176/jiaci.0232. Epub 2018 Jan 18. Review.

39.

Diagnostic challenges in a child with early onset desmoplastic medulloblastoma and homozygous variants in MSH2 and MSH6.

Taeubner J, Wimmer K, Muleris M, Lascols O, Colas C, Fauth C, Brozou T, Felsberg J, Riemer J, Gombert M, Ginzel S, Hoell JI, Borkhardt A, Kuhlen M.

Eur J Hum Genet. 2018 Mar;26(3):440-444. doi: 10.1038/s41431-017-0071-5. Epub 2018 Jan 4.

40.

Regio- and Stereoselective Iron-Catalyzed Oxyazidation of Enamides Using a Hypervalent Iodine Reagent.

Bertho S, Rey-Rodriguez R, Colas C, Retailleau P, Gillaizeau I.

Chemistry. 2017 Dec 14;23(70):17674-17677. doi: 10.1002/chem.201704499. Epub 2017 Nov 30.

PMID:
29143478
41.

Chemical Modulation of the Human Oligopeptide Transporter 1, hPepT1.

Colas C, Masuda M, Sugio K, Miyauchi S, Hu Y, Smith DE, Schlessinger A.

Mol Pharm. 2017 Dec 4;14(12):4685-4693. doi: 10.1021/acs.molpharmaceut.7b00775. Epub 2017 Nov 15.

42.

Surveillance of Duodenal Polyposis in Familial Adenomatous Polyposis: Should the Spigelman Score Be Modified?

Sourrouille I, Lefèvre JH, Shields C, Colas C, Bellanger J, Desaint B, Paye F, Tiret E, Parc Y.

Dis Colon Rectum. 2017 Nov;60(11):1137-1146. doi: 10.1097/DCR.0000000000000903.

PMID:
28991077
43.

The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon Tumors.

Marisa L, Svrcek M, Collura A, Becht E, Cervera P, Wanherdrick K, Buhard O, Goloudina A, Jonchère V, Selves J, Milano G, Guenot D, Cohen R, Colas C, Laurent-Puig P, Olschwang S, Lefèvre JH, Parc Y, Boige V, Lepage C, André T, Fléjou JF, Dérangère V, Ghiringhelli F, de Reynies A, Duval A.

J Natl Cancer Inst. 2018 Jan 1;110(1). doi: 10.1093/jnci/djx136.

PMID:
28922790
44.

Mapping Functionally Important Residues in the Na+/Dicarboxylate Cotransporter, NaDC1.

Colas C, Schlessinger A, Pajor AM.

Biochemistry. 2017 Aug 22;56(33):4432-4441. doi: 10.1021/acs.biochem.7b00503. Epub 2017 Aug 10.

PMID:
28731330
45.
46.

Clinicopathologic Characteristics of Endometrial Cancer in Lynch Syndrome: A French Multicenter Study.

Rossi L, Le Frere-Belda MA, Laurent-Puig P, Buecher B, De Pauw A, Stoppa-Lyonnet D, Canlorbe G, Caron O, Borghese B, Colas C, Delhomelle H, Chabbert-Buffet N, Grandjouan S, Lecuru F, Bats AS.

Int J Gynecol Cancer. 2017 Jun;27(5):953-960. doi: 10.1097/IGC.0000000000000985.

PMID:
28525912
47.

A relevant IgE-reactive 28kDa protein identified from Salsola kali pollen extract by proteomics is a natural degradation product of an integral 47kDa polygalaturonase.

Mas S, Oeo-Santos C, Cuesta-Herranz J, Díaz-Perales A, Colás C, Fernández J, Barber D, Rodríguez R, de Los Ríos V, Barderas R, Villalba M.

Biochim Biophys Acta Proteins Proteom. 2017 Aug;1865(8):1067-1076. doi: 10.1016/j.bbapap.2017.05.007. Epub 2017 May 10.

PMID:
28502749
48.

Aspirin desensitization in patients with coronary artery disease: Cost savings.

Cubero JL, Simó Sánchez B, Millán P, Colás C.

Med Intensiva. 2017 Oct;41(7):446-447. doi: 10.1016/j.medin.2016.09.012. Epub 2017 Feb 11. English, Spanish. No abstract available.

49.

Results of a 1-year quality-improvement process to reduce door-to-needle time in acute ischemic stroke with MRI screening.

Sablot D, Gaillard N, Colas C, Smadja P, Gely C, Dutray A, Bonnec JM, Jurici S, Farouil G, Ferraro-Allou A, Jantac M, Allou T, Pujol C, Olivier N, Laverdure A, Fadat B, Mas J, Dumitrana A, Garcia Y, Touzani H, Perucho P, Moulin T, Richard C, Heroum C, Bouly S, Sagnes-Raffy C, Heve D.

Rev Neurol (Paris). 2017 Jan - Feb;173(1-2):47-54. doi: 10.1016/j.neurol.2016.12.032. Epub 2017 Jan 26.

PMID:
28131535
50.

Structure activity relationships of benzylproline-derived inhibitors of the glutamine transporter ASCT2.

Singh K, Tanui R, Gameiro A, Eisenberg G, Colas C, Schlessinger A, Grewer C.

Bioorg Med Chem Lett. 2017 Feb 1;27(3):398-402. doi: 10.1016/j.bmcl.2016.12.063. Epub 2016 Dec 27.

Supplemental Content

Support Center